Aquestive Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Aquestive Therapeutics stock have an average target of 10.57, with a low estimate of 7.00 and a high estimate of 17. The average target predicts an increase of 298.87% from the current stock price of 2.65.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$10.57	$10	$17
Change	+164.15%	+298.87%	+277.36%	+541.51%

Analyst Ratings

The average analyst rating for Aquestive Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	2
Buy	5	5	6	6	6	5
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	8	8	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Thomas Flaten Lake Street	Lake Street	Strong Buy Maintains $10 → $8	Strong Buy	Maintains	$10 → $8	+201.89%	Mar 7, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+277.36%	Dec 20, 2024
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $17	Buy	Initiates	$17	+541.51%	Dec 17, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+277.36%	Nov 11, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+277.36%	Nov 6, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

54.01M

from 57.56M

-6.17%

from 57.56M

Revenue Next Year

73.30M

from 54.01M

35.72%

from 54.01M

EPS This Year

-0.62

from -0.51

EPS Next Year

-0.54

from -0.62

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	45.85M	50.83M	47.68M	50.58M	57.56M	54.01M	73.30M	140.22M
Revenue Growth	-12.85%	10.87%	-6.20%	6.09%	13.80%	-6.17%	35.72%	91.30%
EPS	-1.66	-1.85	-1.12	-0.13	-0.51	-0.62	-0.54	-0.09
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	7	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	65.1M	92.8M	158.6M
Avg	54.0M	73.3M	140.2M
Low	41.5M	45.1M	124.1M

Revenue Growth

Revenue Growth	2025	2026	2027
High	13.1%	71.9%	116.3%
Avg	-6.2%	35.7%	91.3%
Low	-28.0%	-16.5%	69.3%

EPS Forecast

EPS	2025	2026	2027
High	-0.50	-0.27	-0.09
Avg	-0.62	-0.54	-0.09
Low	-0.76	-0.71	-0.09

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.